Institutional investors purchased a net $2.5 million shares of TROV during the quarter ended March 2015, and now own 30.52% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TEKLA CAPITAL MANAGEMENT LLC Bought 650.0 Thousand shares of Trovagene Inc
RA CAPITAL MANAGEMENT LLC Bought 594.2 Thousand shares of Trovagene Inc